471 related articles for article (PubMed ID: 26744525)
21. Influence of KIR genes and their HLA ligands in susceptibility to dengue in a population from southern Brazil.
Beltrame LM; Sell AM; Moliterno RA; Clementino SL; Cardozo DM; Dalalio MM; Fonzar UJ; Visentainer JE
Tissue Antigens; 2013 Dec; 82(6):397-404. PubMed ID: 24498996
[TBL] [Abstract][Full Text] [Related]
22. Increased frequencies of the killer immunoglobulin-like receptor genes KIR2DL2 and KIR2DS2 are associated with neuroblastoma.
Keating SE; Ní Chorcora C; Dring MM; Stallings RL; O'Meara A; Gardiner CM
Tissue Antigens; 2015 Sep; 86(3):172-7. PubMed ID: 26202659
[TBL] [Abstract][Full Text] [Related]
23. Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection.
Littera R; Chessa L; Deidda S; Angioni G; Campagna M; Lai S; Melis M; Cipri S; Firinu D; Santus S; Lai A; Porcella R; Rassu S; Meloni F; Schirru D; Cordeddu W; Kowalik MA; Ragatzu P; Vacca M; Cannas F; Alba F; Carta MG; Del Giacco S; Restivo A; Deidda S; Palimodde A; Congera P; Perra R; Orrù G; Pes F; Loi M; Murru C; Urru E; Onali S; Coghe F; Giglio S; Perra A
PLoS One; 2021; 16(8):e0255608. PubMed ID: 34352002
[TBL] [Abstract][Full Text] [Related]
24. Association of KIR Genes and MHC Class I Ligands with Atopic Dermatitis.
Margolis DJ; Mitra N; Hoffstad OJ; Kim BS; Monos DS; Phillips EJ
J Immunol; 2021 Sep; 207(6):1522-1529. PubMed ID: 34408014
[TBL] [Abstract][Full Text] [Related]
25. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
[TBL] [Abstract][Full Text] [Related]
26. Role of Donor Activating KIR-HLA Ligand-Mediated NK Cell Education Status in Control of Malignancy in Hematopoietic Cell Transplant Recipients.
Nowak J; Kościńska K; Mika-Witkowska R; Rogatko-Koroś M; Mizia S; Jaskuła E; Polak M; Mordak-Domagała M; Lange J; Gronkowska A; Jędrzejczak WW; Kyrcz-Krzemień S; Markiewicz M; Dzierżak-Mietła M; Tomaszewska A; Nasiłowska-Adamska B; Szczepiński A; Hałaburda K; Hellmann A; Czyż A; Gil L; Komarnicki M; Wachowiak J; Barańska M; Kowalczyk J; Drabko K; Goździk J; Wysoczańska B; Bogunia-Kubik K; Graczyk-Pol E; Witkowska A; Marosz-Rudnicka A; Nestorowicz K; Dziopa J; Szlendak U; Warzocha K; Lange A;
Biol Blood Marrow Transplant; 2015 May; 21(5):829-39. PubMed ID: 25617806
[TBL] [Abstract][Full Text] [Related]
27. The Relationship Between Killer Cell Immunoglobulin-Like Receptors and HLA-C Polymorphisms in Colorectal Cancer in a Saudi Population.
Al Omar SY; Mansour L; Dar JA; Alwasel S; Alkhuriji A; Arafah M; Al Obeed O; Christmas S
Genet Test Mol Biomarkers; 2015 Nov; 19(11):617-22. PubMed ID: 26383988
[TBL] [Abstract][Full Text] [Related]
28. HLA and killer immunoglobulin-like receptor genes as outcome predictors of hepatitis C virus-related hepatocellular carcinoma.
Cariani E; Pilli M; Zerbini A; Rota C; Olivani A; Zanelli P; Zanetti A; Trenti T; Ferrari C; Missale G
Clin Cancer Res; 2013 Oct; 19(19):5465-73. PubMed ID: 23938290
[TBL] [Abstract][Full Text] [Related]
29. Association of Killer Cell Immunoglobulin- Like Receptor Genes in Iranian Patients with Rheumatoid Arthritis.
Nazari M; Mahmoudi M; Rahmani F; Akhlaghi M; Beigy M; Azarian M; Shamsian E; Akhtari M; Mansouri R
PLoS One; 2015; 10(12):e0143757. PubMed ID: 26658904
[TBL] [Abstract][Full Text] [Related]
30. Susceptibility to pulmonary tuberculosis in Iranian individuals is not affected by compound KIR/HLA genotype.
Tajik N; Shah-hosseini A; Mohammadi A; Jafari M; Nasiri M; Radjabzadeh MF; Farnia P; Jalali A
Tissue Antigens; 2012 Feb; 79(2):90-6. PubMed ID: 22128749
[TBL] [Abstract][Full Text] [Related]
31. The role of missing killer cell immunoglobulin-like receptor ligands in T cell replete peripheral blood stem cell transplantation from HLA-identical siblings.
Clausen J; Kircher B; Auberger J; Schumacher P; Ulmer H; Hetzenauer G; Wolf D; Gastl G; Nachbaur D
Biol Blood Marrow Transplant; 2010 Feb; 16(2):273-80. PubMed ID: 19857587
[TBL] [Abstract][Full Text] [Related]
32. Killer immunoglobulin-like receptor repertoire analysis in a Caucasian Spanish cohort with inflammatory bowel disease.
López-Hernández R; Campillo JA; Legaz I; Valdés M; Salama H; Boix F; Hernández-Martínez AM; Eguia J; González-Martínez G; Moya-Quiles MR; Minguela A; García-Alonso A; Carballo F; Muro M
Microbiol Immunol; 2016 Nov; 60(11):787-792. PubMed ID: 27797112
[TBL] [Abstract][Full Text] [Related]
33. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function.
Yawata M; Yawata N; Draghi M; Little AM; Partheniou F; Parham P
J Exp Med; 2006 Mar; 203(3):633-45. PubMed ID: 16533882
[TBL] [Abstract][Full Text] [Related]
34. Killer-cell immunoglobulin-like receptor (KIR) and human leukocyte antigen (HLA) class I genetic diversity in four South African populations.
Gentle NL; Loubser S; Paximadis M; Puren A; Tiemessen CT
Hum Immunol; 2017; 78(7-8):503-509. PubMed ID: 28571758
[TBL] [Abstract][Full Text] [Related]
35. Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation.
David G; Djaoud Z; Willem C; Legrand N; Rettman P; Gagne K; Cesbron A; Retière C
J Immunol; 2013 Nov; 191(9):4778-88. PubMed ID: 24078689
[TBL] [Abstract][Full Text] [Related]
36. KIR gene mismatching and KIR/C ligands in liver transplantation: consequences for short-term liver allograft injury.
Legaz I; López-Álvarez MR; Campillo JA; Moya-Quiles MR; Bolarín JM; de la Peña J; Salgado G; Gimeno L; García-Alonso AM; Muro M; Miras M; Alonso C; Álvarez-López MR; Minguela A
Transplantation; 2013 Apr; 95(8):1037-44. PubMed ID: 23478359
[TBL] [Abstract][Full Text] [Related]
37. Peptide: MHC-based DNA vaccination strategy to activate natural killer cells by targeting killer cell immunoglobulin-like receptors.
Rettman P; Blunt MD; Fulton RJ; Vallejo AF; Bastidas-Legarda LY; España-Serrano L; Polak ME; Al-Shamkhani A; Retiere C; Khakoo SI
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34016721
[TBL] [Abstract][Full Text] [Related]
38. Genetic associations of killer immunoglobulin like receptors and class I human leukocyte antigens on childhood acute lymphoblastic leukemia among north Indians.
Misra MK; Prakash S; Moulik NR; Kumar A; Agrawal S
Hum Immunol; 2016 Jan; 77(1):41-46. PubMed ID: 26472014
[TBL] [Abstract][Full Text] [Related]
39. HLA-Cw polypmorphism and killer cell immunoglobulin-like receptor (KIR) gene analysis in Korean colorectal cancer patients.
Kim HJ; Choi HB; Jang JP; Baek IC; Choi EJ; Park M; Kim TG; Oh ST
Int J Surg; 2014; 12(8):815-20. PubMed ID: 24998207
[TBL] [Abstract][Full Text] [Related]
40. Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells.
Verheyden S; Ferrone S; Mulder A; Claas FH; Schots R; De Moerloose B; Benoit Y; Demanet C
Cancer Immunol Immunother; 2009 Jun; 58(6):855-65. PubMed ID: 18841361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
